Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 43

Sort by

Sort Order Select

Journal Articles

Abstract 691: Irradiated whole tumor cells pulsed with mannan-BAM, TLR ligands and anti-CD40 antibody serve as a potent tumor cell vaccine against glioblastoma

Herui Wang, Rogelio Medina, Juan Ye, Samik Chakraborty, Ondrej Uher, Mitchell Sun, Jan Zenka, Mark R. Gilbert, Karel Pacak, Zhengping Zhuang

Cancer Res (2023) 83 (7_Supplement): 691.

https://doi.org/10.1158/1538-7445.AM2023-691

Published: 04 April 2023

View article titled, Abstract 691: Irradiated whole tumor cells pulsed with mannan-BAM, TLR ligands and anti-CD40 antibody serve as a potent tumor cell vaccine against glioblastoma

Journal Articles

Abstract 6800: Unique autologous cancer vaccine comprised of irradiated whole tumor cells and MBTA (rWTC-MBTA) triggers antitumor immune response to prevent metastasis

Juan Ye, Herui Wang, Mitchell Sun, Ondrej Uher, Mark R. Gilbert, Karel Pacak, Zhengping Zhuang, Rogelio Medina, Samik Chakraborty, Jan Zenka

Cancer Res (2023) 83 (7_Supplement): 6800.

https://doi.org/10.1158/1538-7445.AM2023-6800

Published: 04 April 2023

View article titled, Abstract 6800: Unique autologous cancer vaccine comprised of irradiated whole tumor cells and MBTA (rWTC-MBTA) triggers antitumor immune response to prevent metastasis

Journal Articles

Abstract 2260: Targeting PP2A with LB100 enhances efficacy of CAIX CAR-T cells against GBM

Jing Cui, Qi Zhang, Qi Song, Herui Wang, Pauline Dmitriev, Mitchell Sun, Jared S. Rosenblum, Kaiyong Yang, John Kovach, Mark R. Gilbert, Zhengping Zhuang

Cancer Res (2019) 79 (13_Supplement): 2260.

https://doi.org/10.1158/1538-7445.AM2019-2260

Published: 01 July 2019

View article titled, Abstract 2260: Targeting PP2A with LB100 enhances efficacy of CAIX CAR-T cells against GBM

Journal Articles

Acetylation within the N- and C-Terminal Domains of Src Regulates Distinct Roles of STAT3-Mediated Tumorigenesis

Chao Huang, Zhe Zhang, Lihan Chen, Hank W. Lee, Marina K. Ayrapetov, Ting C. Zhao, Yimei Hao, Jinsong Gao, Chunzhang Yang, Gautam U. Mehta, Zhengping Zhuang, Xiaoren Zhang, Guohong Hu, Y. Eugene Chin

Cancer Res (2018) 78 (11): 2825–2838.

https://doi.org/10.1158/0008-5472.CAN-17-2314

Published: 31 May 2018

View article titled, Acetylation within the N- and C-Terminal Domains of Src Regulates Distinct Roles of STAT3-Mediated Tumorigenesis

Includes: Supplementary data

Journal Articles

Deletion of the von Hippel-Lindau Gene in Hemangioblasts Causes Hemangioblastoma-like Lesions in Murine Retina

Herui Wang, Matthew J. Shepard, Chao Zhang, Lijin Dong, Dyvon Walker, Liliana Guedez, Stanley Park, Yujuan Wang, Shida Chen, Ying Pang, Qi Zhang, Chun Gao, Wai T. Wong, Henry Wiley, Karel Pacak, Emily Y. Chew, Zhengping Zhuang, Chi-Chao Chan

Cancer Res (2018) 78 (5): 1266–1274.

https://doi.org/10.1158/0008-5472.CAN-17-1718

Published: 28 February 2018

View article titled, Deletion of the von Hippel-Lindau Gene in Hemangioblasts Causes Hemangioblastoma-like Lesions in Murine Retina

Journal Articles

Abstract LB-193: Protein phosphatase 2A inhibition,with a novel small molecule inhibitor, LB-100, achieves durable immune-mediated antitumor activity when combined with PD1 blockade in a preclinical model

Winson S. Ho, Herui Wang, John S. Kovach, Rongze Lu, Zhengping Zhuang

Cancer Res (2017) 77 (13_Supplement): LB-193.

https://doi.org/10.1158/1538-7445.AM2017-LB-193

Published: 01 July 2017

View article titled, Abstract LB-193: Protein phosphatase 2A inhibition,with a novel small molecule inhibitor, LB-100, achieves durable immune-mediated antitumor activity when combined with PD1 blockade in a preclinical model

Journal Articles

Abstract 1851: A murine model of von Hippel-Lindau associated retinal hemangioblastoma

Herui Wang, Qi Zhang, Lijin Dong, Liliana Guedez, Stanley Park, Yujuan Wang, Shida Chen, Chun Gao, Wai T. Wong, Henry Wiley, Emily Chew, Chi-Chao Chan, Zhengping Zhuang

Cancer Res (2017) 77 (13_Supplement): 1851.

https://doi.org/10.1158/1538-7445.AM2017-1851

Published: 01 July 2017

View article titled, Abstract 1851: A murine model of von Hippel-Lindau associated retinal hemangioblastoma

Journal Articles

Abstract 3807: Histone deacetylase inhibitors repress hypoxia signaling through affecting Hsp90

Chunzhang Yang, Zhengping Zhuang

Cancer Res (2016) 76 (14_Supplement): 3807.

https://doi.org/10.1158/1538-7445.AM2016-3807

Published: 15 July 2016

View article titled, Abstract 3807: Histone deacetylase inhibitors repress hypoxia signaling through affecting Hsp90

Journal Articles

Abstract 3943: Genetic abnormalites in hypoxia sensing regulators cause human pheochromocytoma/paraganglioma and plolycythemia syndrome

Chunzhang Yang, Herui Wang, Karel Pacak, Zhengping Zhuang

Cancer Res (2015) 75 (15_Supplement): 3943.

https://doi.org/10.1158/1538-7445.AM2015-3943

Published: 01 August 2015

View article titled, Abstract 3943: Genetic abnormalites in hypoxia sensing regulators cause human pheochromocytoma/paraganglioma and plolycythemia syndrome

Journal Articles

Abstract 19: Novel HIF2A mutations disrupting oxygen sensing lead to a new syndrome of multiple paragangliomas and somatostatinomas associated with polycythemia

Chunzhang Yang, Karel Pacak, Zhengping Zhuang

Cancer Res (2014) 74 (23_Supplement): 19.

https://doi.org/10.1158/1538-7445.CANSUSC14-19

Published: 12 December 2014

View article titled, Abstract 19: Novel HIF2A mutations disrupting oxygen sensing lead to a new syndrome of multiple paragangliomas and somatostatinomas associated with polycythemia

Journal Articles

Abstract 4399: Somatic HIF2A mutations identified in a new syndrome with multiple paragangliomas and somatostatinomas associated with polycythemia

Chunzhang Yang, Karel Pacak, Zhengping Zhuang

Cancer Res (2014) 74 (19_Supplement): 4399.

https://doi.org/10.1158/1538-7445.AM2014-4399

Published: 01 October 2014

View article titled, Abstract 4399: Somatic HIF2A mutations identified in a new syndrome with multiple paragangliomas and somatostatinomas associated with polycythemia

Journal Articles

Abstract 4220: Beta-catenin signaling initiates the activation of astrocytes and contributes to the pathogenesis of astrocytomas

Chunzhang Yang, Rajiv Iyer, Barbara Ikejiri, Russell Lonser, Zhengping Zhuang

Cancer Res (2012) 72 (8_Supplement): 4220.

https://doi.org/10.1158/1538-7445.AM2012-4220

Published: 15 April 2012

View article titled, Abstract 4220: Beta-catenin signaling initiates the activation of astrocytes and contributes to the pathogenesis of astrocytomas

Journal Articles

Abstract 5497: An inhibitor of phosphatase PP2A enhances in vivo anticancer activity of a phospho (ADP-ribosyl) polymerase inhibitor (PARPi) combined with temozolomide (TMZ)

Jie Lu, Barbara Ikejiri, Chunzhang Yang, Eli Thompson, Harry Mushlin, John S. Kovach, Russell Lonser, Zhengping Zhuang

Cancer Res (2011) 71 (8_Supplement): 5497.

https://doi.org/10.1158/1538-7445.AM2011-5497

Published: 15 April 2011

View article titled, Abstract 5497: An inhibitor of phosphatase PP2A enhances in vivo anticancer activity of a phospho (ADP-ribosyl) polymerase inhibitor (PARPi) combined with temozolomide (TMZ)

Journal Articles

LB-1, an inhibitor of serine-threonine protein phosphatase PP2A, suppresses the growth of glioblastoma cells in vitro and in vivo

Jie Lu, Barbara Ikejiri, Nahal Golpayegani, Stephanie Kim, Harry Mushlin, Francis Johnson, John Kovach, Russell Lonser, Zhengping Zhuang

Cancer Res (2008) 68 (9_Supplement): 5693.

Published: 01 May 2008

View article titled, LB-1, an inhibitor of serine-threonine protein phosphatase PP2A, suppresses the growth of glioblastoma cells in vitro and in vivo

Journal Articles

Discovery and validation of astrocytoma biomarkers using microdissected tissue specimens coupled with targeted and mass spectrometry-based proteomic studies

Weijie Wang, Haifeng Xu, Zhengping Zhuang, Robert Weil, Cheng Lee, Brian Balgley

Cancer Res (2008) 68 (9_Supplement): 4499.

Published: 01 May 2008

View article titled, Discovery and validation of astrocytoma biomarkers using microdissected tissue specimens coupled with targeted and mass spectrometry-based proteomic studies

Journal Articles

Discovery and validation of astrocytoma biomarkers using microdissected tissue specimens coupled with targeted and mass spectrometry-based proteomic studies

Weije Wang, Tong Guo, Cheng Lee, Zhengping Zhuang, Robert Weil, Brian Balgley

Cancer Res (2007) 67 (9_Supplement): 3138.

Published: 01 May 2007

View article titled, Discovery and validation of astrocytoma biomarkers using microdissected tissue specimens coupled with targeted and mass spectrometry-based proteomic studies

Journal Articles

Comparative Proteomic Profiles of Meningioma Subtypes

Hiroaki Okamoto, Jie Li, Alexander O. Vortmeyer, Howard Jaffe, Youn-Soo Lee, Sven Gläsker, Tae-Sung Sohn, Weifen Zeng, Barbara Ikejiri, Martin A. Proescholdt, Christina Mayer, Robert J. Weil, Edward H. Oldfield, Zhengping Zhuang

Cancer Res (2006) 66 (20): 10199–10204.

https://doi.org/10.1158/0008-5472.CAN-06-0955

Published: 17 October 2006

View article titled, Comparative Proteomic Profiles of Meningioma Subtypes

Journal Articles

Hemangioblastomas Share Protein Expression with Embryonal Hemangioblast Progenitor Cell

Sven Gläsker, Jie Li, John B. Xia, Hiroaki Okamoto, Weifen Zeng, Russell R. Lonser, Zhengping Zhuang, Edward H. Oldfield, Alexander O. Vortmeyer

Cancer Res (2006) 66 (8): 4167–4172.

https://doi.org/10.1158/0008-5472.CAN-05-3505

Published: 17 April 2006

View article titled, Hemangioblastomas Share Protein Expression with Embryonal Hemangioblast Progenitor Cell

Journal Articles

Proteomic profiling distinguishes astrocytomas of different grades and identifies differential tumor markers

Jie Li, Robert Weil, Hiroaki Okamoto, Alexander Vortmeyer, Irina Lubensky, Deric Park, Makoto Furuta, Youn-Soo Lee, Weifen Zeng, Edward H. Oldfield, Zhengping Zhuang

Cancer Res (2006) 66 (8_Supplement): 432.

Published: 15 April 2006

View article titled, Proteomic profiling distinguishes astrocytomas of different grades and identifies differential tumor markers

Journal Articles

Effects of VHL Deficiency on Endolymphatic Duct and Sac

Sven Gläsker, Russell R. Lonser, Maxine G.B. Tran, Barbara Ikejiri, John A. Butman, Weifen Zeng, Patrick H. Maxwell, Zhengping Zhuang, Edward H. Oldfield, Alexander O. Vortmeyer

Cancer Res (2005) 65 (23): 10847–10853.

https://doi.org/10.1158/0008-5472.CAN-05-1104

Published: 01 December 2005

View article titled, Effects of <em>VHL</em> Deficiency on Endolymphatic Duct and Sac

NARROW

Abstract 691: Irradiated whole tumor cells pulsed with mannan-BAM, TLR ligands and anti-CD40 antibody serve as a potent tumor cell vaccine against glioblastoma

Abstract 6800: Unique autologous cancer vaccine comprised of irradiated whole tumor cells and MBTA (rWTC-MBTA) triggers antitumor immune response to prevent metastasis

Abstract 2260: Targeting PP2A with LB100 enhances efficacy of CAIX CAR-T cells against GBM

Acetylation within the N- and C-Terminal Domains of Src Regulates Distinct Roles of STAT3-Mediated Tumorigenesis

Deletion of the von Hippel-Lindau Gene in Hemangioblasts Causes Hemangioblastoma-like Lesions in Murine Retina

Abstract LB-193: Protein phosphatase 2A inhibition,with a novel small molecule inhibitor, LB-100, achieves durable immune-mediated antitumor activity when combined with PD1 blockade in a preclinical model

Abstract 1851: A murine model of von Hippel-Lindau associated retinal hemangioblastoma

Abstract 3807: Histone deacetylase inhibitors repress hypoxia signaling through affecting Hsp90

Abstract 3943: Genetic abnormalites in hypoxia sensing regulators cause human pheochromocytoma/paraganglioma and plolycythemia syndrome

Abstract 19: Novel HIF2A mutations disrupting oxygen sensing lead to a new syndrome of multiple paragangliomas and somatostatinomas associated with polycythemia

Abstract 4399: Somatic HIF2A mutations identified in a new syndrome with multiple paragangliomas and somatostatinomas associated with polycythemia

Abstract 4220: Beta-catenin signaling initiates the activation of astrocytes and contributes to the pathogenesis of astrocytomas

Abstract 5497: An inhibitor of phosphatase PP2A enhances in vivo anticancer activity of a phospho (ADP-ribosyl) polymerase inhibitor (PARPi) combined with temozolomide (TMZ)

LB-1, an inhibitor of serine-threonine protein phosphatase PP2A, suppresses the growth of glioblastoma cells in vitro and in vivo

Discovery and validation of astrocytoma biomarkers using microdissected tissue specimens coupled with targeted and mass spectrometry-based proteomic studies

Discovery and validation of astrocytoma biomarkers using microdissected tissue specimens coupled with targeted and mass spectrometry-based proteomic studies

Comparative Proteomic Profiles of Meningioma Subtypes

Hemangioblastomas Share Protein Expression with Embryonal Hemangioblast Progenitor Cell

Proteomic profiling distinguishes astrocytomas of different grades and identifies differential tumor markers

Effects of VHL Deficiency on Endolymphatic Duct and Sac

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only